AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
22.54
-1.15 (-4.85%)
At close: Aug 6, 2025, 4:00 PM
24.85
+2.31 (10.25%)
After-hours: Aug 6, 2025, 6:24 PM EDT
AnaptysBio Stock Forecast
Stock Price Forecast
The 8 analysts that cover AnaptysBio stock have a consensus rating of "Buy" and an average price target of $49, which forecasts a 117.39% increase in the stock price over the next year. The lowest target is $20 and the highest is $90.
Price Target: $49.00 (+117.39%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AnaptysBio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 4 | 4 | 4 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $42 → $80 | Buy | Maintains | $42 → $80 | +254.92% | Jul 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $22 → $38 | Hold → Strong Buy | Upgrades | $22 → $38 | +68.59% | Jun 4, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $54 → $90 | Strong Buy | Maintains | $54 → $90 | +299.29% | May 28, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $52 → $54 | Strong Buy | Maintains | $52 → $54 | +139.57% | May 6, 2025 |
| Wedbush | Wedbush | Buy Reiterates $40 | Buy | Reiterates | $40 | +77.46% | May 1, 2025 |
Financial Forecast
Revenue This Year
66.99M
from 91.28M
Decreased by -26.61%
Revenue Next Year
83.32M
from 66.99M
Increased by 24.39%
EPS This Year
-5.41
from -5.12
EPS Next Year
-5.06
from -5.41
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 149.7M | 216.3M | 196.1M | ||
| Avg | 67.0M | 83.3M | 103.5M | ||
| Low | 27.2M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 64.0% | 222.9% | 135.4% | ||
| Avg | -26.6% | 24.4% | 24.2% | ||
| Low | -70.2% | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.09 | -1.56 | -3.02 | ||
| Avg | -5.41 | -5.06 | -5.58 | ||
| Low | -6.88 | -6.76 | -9.76 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.